| Revenue growth | Value |
|---|---|
| 3Y CAGR | +46% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +92% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Astrazeneca Pharma IndiaASTRAZEN | ₹8,512.50 +9.50 (0.11%) | 21,249.25 | 113.31 | 24.35 | ||
PfizerPFIZER | ₹4,493.50 -9.60 (0.21%) | 20,597.46 | 28.51 | 4.9 | ||
₹1,411.10 +34.60 (2.51%) | 19,081.41 | 29.47 | 4.89 | |||
Granules IndiaGRANULES | ₹741.40 -6.95 (0.93%) | 18,557.51 | 31.19 | 3.65 |